NCT05318573 2025-09-04A Study to Evaluate Safety, Efficacy of FF-10832 in Combo With Pembrolizumab in Urothelial & Non-small Cell Lung CancerFujifilm Pharmaceuticals U.S.A., Inc.Phase 2 Active not recruiting120 enrolled